Advancing Bone Graft TechnologyA Surgeon’s Vision
“As a practicing orthopedic surgeon, I have used fluorine to effectively treat osteoporosis patients, but its availability was banned by the Indian government due to concerns about overexposure. At the same time, I frequently encounter patients suffering from the devastating effects of chronic fluorosis, particularly those with cervical compressive myelopathy. This extreme contrast—fluorine’s immense therapeutic potential and its hazardous consequences—sparked my determination to explore a balanced approach. My focus has been on optimizing fluorine concentration in phosphate-based bioglass to leverage its bone anabolic properties while minimizing risks. This research has led to the development of a truly innovative bone graft substitute.”
For Dr.S PugalanthiPandian, a dedicated Orthopedic and Neurosurgeon, the quest for better synthetic bone substitutes has been more than just a professional pursuit—it has been a lifelong passion driven by firsthand experience in treating patients with complex bone disorders.
With 40 years of experience in orthopedic surgery, Dr.Pandian has witnessed the dual nature of fluorine in bone health. On one hand, fluorine has shown remarkable potential in treating osteoporosis, aiding in bone regeneration and strengthening skeletal structures. On the other hand, chronic fluorosis—caused by excessive fluorine exposure—has led to severe complications such as cervical compressive myelopathy, a debilitating condition that often requires surgical intervention like laminoplasty.
This deep understanding of bone biology, surgical challenges, and material science has culminated in the creation of a next-generation synthetic bone graft—one that offers an optimal balance of safety, efficacy, and regenerative potential.
With this breakthrough, Dr.Pandian’s vision is to revolutionize the field of bone grafting, providing medical device manufacturers, biotech firms, and healthcare professionals with a superior alternative that enhances bone healing, integration, and long-term patient outcomes.
Advancing Bone Graft TechnologyPatent Offering
We are offering an exclusive opportunity to acquire our patented innovation, “A SYNTHETIC COMPOSITE AS BONE GRAFT AND THE METHOD THEREOF.”
This next-generation synthetic bone graft is designed to accelerate bone healing and integration, providing a superior alternative to conventional solutions.
This breakthrough technology is ideal for medical device manufacturers, biotech firms, and health care investors looking to stay ahead in the bone graft industry
Faster Bone Regeneration
Promotes high osteo-conversion within few weeks
Enhanced Compatibility
Offers osteoconductive, osteoinductive, and osteo-convertible properties
Versatile Forms
Available as granules, strips, and cylinders
A SYNTHETIC COMPOSITE AS BONE GRAFT AND THE METHOD THEREOF
Granted
India
Granted
South Africa
Granted
China
Granted
Singapore
Granted
Australia
Novelty Accepted, Claims Modified
Saudi Arabia
Novelty Accepted, Claims Modified
Canada
Novelty Accepted, Claims Modified
European Union
Novelty Accepted, Claims Modified
UAE
In Progress
USA
In Progress
South Korea
Revolutionizing Wound Healing: A Breakthrough Ointment for Faster RecoveryPatent Offering
Our patented ointment, formulated with Nano powder of Magnesium Fluoro Phosphate, has demonstrated remarkable efficacy. Lab studies confirm a multifold increase in VEGF, FGF, and EGF stimulation, while animal studies further validate its impact through histopathological, histochemical (VEGF), and immunochemical (Ki67) analyses—revealing comprehensive healing across all 17 key factors.
Now, it’s time to bring this breakthrough to human use, offering new hope to millions suffering from chronic wounds, diabetic ulcers, bedsores, and burn injuries. We are actively seeking manufacturing partners from the pharmaceutical industry to collaborate in bringing this revolutionary ointment to market. We are open to licensing our patented formulation to established pharma companies with expertise in wound care, ensuring that this innovation reaches those who need it most.
Reach Us for Expert GuidanceConnect with us
If you are interested in acquiring or collaborating on this cutting-edge bone graft technology, Seize This Opportunity! Let’s connect!
Contact us to explore acquisition and partnership possibilities.
Call us
Chat us
Mail us
Where Innovation Meets Bone SciencePublications
Published
23 December 2020
Published
3 March 2021
Preparation and Physico-Chemical Characterization Studies of Fluoride Doped Bioceramics (P2O5-CaO-CaF2-Na2O) for Bone Regeneration
Bioceramics Developments and Applications
Published
December 15, 2021
Published
14 August 2022
Published
2024
Magnesium-doped Fluorophosphate Bioactive Glass for Bone Tissue Engineering: in vitro and in vivo study